JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 50 filers reported holding JANUX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,444,704 | -0.7% | 3,317,927 | +17.0% | 0.71% | +16.4% |
Q2 2023 | $33,667,902 | -1.9% | 2,836,386 | 0.0% | 0.61% | -9.5% |
Q1 2023 | $34,320,271 | -8.1% | 2,836,386 | 0.0% | 0.67% | -5.7% |
Q4 2022 | $37,355,204 | -2.7% | 2,836,386 | 0.0% | 0.72% | +0.3% |
Q3 2022 | $38,405,000 | +10.9% | 2,836,386 | 0.0% | 0.71% | +13.5% |
Q2 2022 | $34,632,000 | -14.9% | 2,836,386 | 0.0% | 0.63% | -4.8% |
Q1 2022 | $40,674,000 | -27.3% | 2,836,386 | 0.0% | 0.66% | -8.2% |
Q4 2021 | $55,962,000 | -25.4% | 2,836,386 | -18.2% | 0.72% | -12.7% |
Q3 2021 | $74,978,000 | -13.3% | 3,466,386 | 0.0% | 0.82% | -5.8% |
Q2 2021 | $86,486,000 | – | 3,466,386 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,670,644 | $187,546,000 | 2.60% |
5AM Venture Management, LLC | 446,266 | $9,653,000 | 1.96% |
Samsara BioCapital, LLC | 411,871 | $8,909,000 | 1.40% |
EcoR1 Capital, LLC | 1,411,975 | $30,541,000 | 1.06% |
BVF INC/IL | 1,017,314 | $22,005,000 | 0.86% |
Orbimed Advisors | 3,466,386 | $74,978,000 | 0.82% |
Logos Global Management LP | 247,122 | $4,811,000 | 0.35% |
Woodline Partners LP | 300,031 | $6,490,000 | 0.11% |
Parkwood LLC | 20,777 | $449,000 | 0.05% |
JANUS HENDERSON GROUP PLC | 2,416,404 | $51,375,000 | 0.02% |